Surgery
Prof. Calvin Sze Hang NG
Environmental Foundation Professor of Thoracic Surgery
Department of Surgery, CUHK
Research Area
- Single Port (Uniportal) Minimally Invasive Video-Assisted Thoracic Surgery (VATS)
- Hybrid Operating Room Image-Guided VATS (iVATS) for Small Lung Lesions
- Robotic-Assisted Bronchoscopy (RAB) & Image-Guided Electromagnetic Navigation Bronchoscopy (iENB)
- Microwave & Novel Ablation Techniques for Lung Cancer
- Magnetic Actuated Surgical Endoscopes
- Chest Wall Reconstruction
- Molecular Biology of Lung Cancer
- Nanoparticles & Aptamers in Cancer Therapy
- Inflammatory & Immune Dysfunction following Surgery
Professional Profile
Dr Ng is the endowed Environmental Foundation Professor of Thoracic Surgery at The Chinese University of Hong Kong, and Honorary Consultant Surgeon at Prince of Wales Hospital – New Territory East Cluster (NTEC) hospitals in Hong Kong. He graduated from Imperial College, London in 1999, and was awarded FRCSEd(CTh) in 2007, Doctorate of Medicine in Research (MD(Res)) 2008 from University of London for his work on ventilator induced and IR lung injury.
Dr Ng is a pioneer in Single Port (Uniportal) VATS in the Asia-Pacific region, performing the first single port VATS lobectomy in Hong Kong in 2012. His interest in hybrid operating room (HOR) image-guided surgery led to world’s first publications of HOR use in single port VATS major lung resection (iVATS) in 2015, and image-guided electromagnetic navigation bronchoscopy (iENB) in 2016. In March 2019, he led his world renowned HOR-iENB team to perform Asia-Pacific’s first HOR non-invasive transbronchial microwave ablation of lung cancer. He is Co-PI of NAVABLATE, prospective international study on transbronchial microwave ablation for lung cancer treatment, and has one of world’s largest experience of this technique. His team also performed; the world first IllumisiteTM transbronchial microwave ablation, first Monarch robotic bronchoscopy procedure outside of US in 2021, world first robotic bronchoscopy microwave ablation, first Galaxy robotic bronchoscopy procedure in Asia in 2023 and is Co-PI of INCITE, PSR-Emprint, TARGET, POWER and TiLT trials investigating utilization of alternate ablation energies, and robotic assisted bronchoscopy in diagnosis and therapy.
His academic contributions include 31 book chapters (including in Pearson’s Thoracic & Esophageal Surgery 3rd & 4th Eds, Shield’s Thoracic Surgery 8th Eds), and more than 300 publications in indexed international journals including Lancet, Lancet Oncology, JCO, ERJ, JTO etc (Scopus Citations >7100; H-index 43; Jul-2025).